PRCT Procept BioRobotics Corp

$PRCT massively oversold. Too much emphasis given to potential negative “possibilities”, whilst not enough focus on actual results and future growth trajectory. A growth company that is not being valued correctly.

$PRCT market cap at close on Friday $979M. Strip out the cash $227M and you get EV $752M. With 2026 rev at $400M and 2027 around $500, EBITDA positive in Q4 2026, Cancer treatment online in 2028, over 13,000+ procedures per quarter, margins of 65%……… this must be the cheapest med tech company out there. Someone has to buy this business, they will make a fortune by 2028. Makes no sense to be trading @ $17

$PRCT Barclays initiates coverage on PRCT. Overweight with price target $30. Extensive industry survey. The suggestion is that this is even conservative. As I have indicated, massively oversold and too many people focusing on negatives that are not relevant/material.

$PRCT very concentrated accumulation, if we break this range with a catlayst it is going to be fun to watch it skyrocket

$PRCT hmm... weak in a generally strong tape... could be interesting a couple of years out and the price isnt too shabby either... could retest mid 18s so the reaction in the current range will be telling... lots of potential catalysts also lined up here for the next year...

Been counting $PRCT waves for months, reading every filing. Went in Friday at the close. Why👇 7th Aug : CEO bought $498K while Wall St downgraded. I joined him today 🎯 🟢 Bought $18.41 ➕ Adding $16.80–18 🛑 Stop $16.50 🎯 Half at $22.40, rest $26.50 📉 -84% from $103. Handpiece sales ran 8–16% ahead of real procedures (company's own numbers). 3 drops: -13%, -10%, -15%. 🧹 New CEO from Edwards TAVR cleared inventory and killed the quarter-end incentives. Q2: revenue +19%, guidance held at $390–410M. 💰 Aug 7: CEO buys $498K at ~$20.85 🏦 Oct 6: Barclays Overweight, $30 🤔 🗓️ New CEO hired Jul 24, 2025. Low hit Jul 24, 2026. Reset year done? I think so 📐 Wave 2 held $16.75, 8¢ above the $16.67 base 💪 $231M cash vs $52M debt ✅ Passed my own filters: 7/7 🩳 ~13% of shares short 👀 Close above $18.67 confirms. Q3 ~Nov 3 Could be wrong. The risk is defined. 📌 In May I bought $SHOP at $95, $1 off the low. The stop nearly hit. Sticking to the rules won it, not me. Not advice 🫡 Do your own DD🚨